Press Releases MAIA Biotechnology, Inc.

Equities

MAIA

US5526411021

Real-time Estimate Cboe BZX Other stock markets 14:23:10 2024-05-20 EDT			5-day change	1st Jan Change
3.42 ^USD	+3.32%		+9.28%	+184.87%

04-26	Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	MT
04-22	MAIA Biotechnology, Inc. announced that it expects to receive $0.664994 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024	10:13am	AQ
MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2024 ANNUAL MEETING	05-17	AQ
MAIA Biotechnology to Present at the BIO International Convention 2024	05-17	BU
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting	05-16	BU
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement	04-30	BU
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement	04-29	BU
MAIA Biotechnology Announces $1.00 Million Private Placement	04-23	BU
MAIA BIOTECHNOLOGY TO PRESENT AT TWO INVESTOR CONFERENCES IN APRIL 2024	04-08	AQ
MAIA Biotechnology to Present at Two Investor Conferences in April 2024	04-05	BU
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero	03-28	BU
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement	03-26	BU
MAIA Biotechnology Announces $1.33 Million Private Placement	03-26	BU
MAIA BIOTECHNOLOGY ANNOUNCES SHARE PURCHASE BY DIRECTOR STAN SMITH, PHD IN A $2.9 MILLION PRIVATE PLACEMENT	03-25	AQ
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement	03-22	BU
MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board	03-21	BU
MAIA Biotechnology to Participate in the 36th Annual ROTH Conference	03-07	BU
MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting	03-06	BU
MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients	03-06	BU
MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders	03-05	BU
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor	02-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases MAIA Biotechnology, Inc.

Equities

MAIA

US5526411021

Press Releases

Filters